Abstrakt

Przypisy

• 1. Basile D.P., Friedrich J.L., Spahic J., Knipe N., Mang H., LeonardE.C., Changizi-Ashtiyani S., Bacallao R.L., Molitoris B.A., Sutton T.A.:Impaired endothelial proliferation and mesenchymal transition contributeto vascular rarefaction following acute kidney injury. Am. J.Physiol. Renal Physiol., 2011; 300: F721-F733
  Google Scholar
• 2. Basile D.P., Zeng P., Friedrich J.L., Leonard E.C., Yoder M.C.: Lowproliferative potential and impaired angiogenesis of cultured ratkidney endothelial cells. Microcirculation, 2012; 19: 598-609
  Google Scholar
• 3. Bohle A., Mackensen-Haen S., von Gise H., Grund K.E., WehrmannM., Batz C., Bogenschütz O., Schmitt H., Nagy J., Müller C., Müller G.:The consequences of tubulo-interstitial changes for renal functionin glomerulopathies. A morphometric and cytological analysis. Pathol.Res. Pract., 1990; 186: 135-144
  Google Scholar
• 4. Brenner B.M.: Remission of renal disease: recounting the challenge,acquiring the goal. J. Clin. Invest., 2002; 110: 1753-1758
  Google Scholar
• 5. Brindle N.P., Saharinen P., Alitalo K.: Signaling and functions ofangiopoietin-1 in vascular protection. Circ. Res., 2006; 98: 1014-1023
  Google Scholar
• 6. Campanholle G., Ligresti G., Gharib S.A., Duffield J.S.: Cellular mechanismsof tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.Am. J. Physiol. Cell Physiol., 2013; 304: C591-C603
  Google Scholar
• 7. Carmeliet P.: Angiogenesis in health and disease. Nat. Med., 2003;9: 653-660
  Google Scholar
• 8. Collier P., Ledwidge M., McDonald K.: Diagnostics and therapeuticinterventions in myocardial interstitial disease, a previously neglectedpathology. Q. J. Med., 2012; 105: 721-724
  Google Scholar
• 9. dell’Omo R., Semeraro F., Bamonte G., Cifariello F., Romano M.R.,Costagliola C.: Vitreous mediators in retinal hypoxic diseases. MediatorsInflamm., 2013; 2013: 935301
  Google Scholar
• 10. Deng A., Arndt M.A., Satriano J., Singh P., Rieg T., Thomson S.,Tang T., Blantz R.C.: Renal protection in chronic kidney disease: hypoxia-induciblefactor activation vs. angiotensin II blockade. Am. J.Physiol. Renal Physiol., 2010; 299: F1365-F1373
  Google Scholar
• 11. Donderski R., Szczepanek J., Domagalski K., Tretyn A., KorenkiewiczJ., Marszałek A., Szymański A., Wolski Z., Odrowąż-SypniewskaG., Manitius J.: Analysis of relative expression level of VEGF (vascularendothelial growth factor), HIF-1α (hypoxia inducible factor 1α) andCTGF (connective tissue growth factor) genes in chronic glomerulonephritis(CGN) patients. Kidney Blood Press. Res., 2013; 38: 83-91
  Google Scholar
• 12. Ebrahimi B., Li Z., Eirin A., Zhu X.Y., Textor S.C., Lerman L.O.:Addition of endothelial progenitor cells to renal revascularizationrestores medullary tubular oxygen consumption in swine renal arterystenosis. Am. J. Physiol. Renal Physiol., 2012; 302: F1478-F1485
  Google Scholar
• 13. Eknoyan G., McDonald M.A., Appel D., Truong L.D.: Chronictubule-intertstitial nephritis: correlation between structural andfunctional findings. Kidney Int., 1990; 38: 736-743
  Google Scholar
• 14. Fiedler U., Reiss Y., Scharpfenecker M., Grunow V., Koidl S.,Thurston G., Gale N.W., Witzenrath M., Rosseau S., Suttorp N., SobkeA., Herrmann M., Preissner K.T., Vajkoczy P., Augustin H.G.: Angiopoietin-2sensitizes endothelial cells to TNF-α and has a crucialrole in the induction of inflammation. Nat. Med., 2006; 12: 235-239
  Google Scholar
• 15. Hirschberg R.: Wound healing in the kidney: complex interactionsin renal interstitial fibrogenesis. J. Am. Soc. Nephrol., 2005; 16: 9-11
  Google Scholar
• 16. Kaissling B., Le Hir M.: The renal cortical interstitium: morphologicaland functional aspects. Histochem.Cell Biol., 2008; 130: 247-262
  Google Scholar
• 17. Kang D.H., Hughes J., Mazzali M., Schreiner G.F., Johnson R.J.:Impaired angiogenesis in the remnant kidney model: II. Vascularendothelial growth factor administration reduces renal fibrosis andstabilizes renal function. J. Am. Soc. Nephrol., 2001; 12: 1448-1457
  Google Scholar
• 18. Kang D.H., Joly A.H., Oh S.W., Hugo C., Kerjaschki D., Gordon K.L.,Mazzali M., Jefferson J.A., Hughes J., Madsen K.M., Schreiner G.F.,Johnson R.J.: Impaired angiogenesis in the remnant kidney model:I. Potential role of vascular endothelial growth factor and thrombospondin-1.J. Am. Soc. Nephrol., 2001; 12: 1434-1447
  Google Scholar
• 19. Kang D.H., Nakagawa T., Feng L., Johnson R.J.: Nitric oxide modulatesvascular disease in the remnant kidney model. Am. J. Pathol.,2002; 161: 239-248
  Google Scholar
• 20. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., Koh G.Y.: Angiopoietin-1regulates endothelial cell survival through the phosphatidylinositol3′-Kinase/Akt signal transduction pathway. Circ. Res.,2000; 86: 24-29
  Google Scholar
• 21. Kitayama H., Maeshima Y., Takazawa Y., Yamamoto Y., Wu Y.,Ichinose K., Hirokoshi K., Sugiyama H., Yamasaki Y., Makino H.: Regulationof angiogenic factors in angiotensin II infusion model inassociation with tubulointerstitial injuries. Am. J. Hypertens., 2006;19: 718-727
  Google Scholar
• 22. Lange C.A., Bainbridge J.W.: Oxygen sensing in retinal healthand disease. Ophtalmologica, 2012; 227: 115-131
  Google Scholar
• 23. Li Y., Wingert R.A.: Regenerative medicine for the kidney: stemcell prospects and challenges. Clin. Transl. Med., 2013; 2: 11
  Google Scholar
• 24. Maeshima Y., Makino H.: Angiogenesis and chronic kidney disease.Fibrogenesis Tissue Repair, 2010; 3: 13
  Google Scholar
• 25. Matsumoto Y., Ueda S., Yamagishi S., Matsuguma K., Shibata R.,Fukami K., Matsuoka H., Imaizumi T., Okuda S.: Dimethylarginine dimethylaminohydrolaseprevents progression of renal dysfunctionby inhibiting loss of peritubular capillaries and tubulointerstitialfibrosis in a rat model of chronic kidney disease. J. Am. Soc. Nephrol.,2007; 18: 1525-1533
  Google Scholar
• 26. Mimura I., Nangaku M.: The suffocating kidney: tubulointerstitialhypoxia in end-stage renal disease. Nat. Rev. Nephrol., 2010; 6: 667-678
  Google Scholar
• 27. Nakayama M.,Nakayama A., van Lessen M., Yamamoto H., HoffmannS., Drexler H.C., Itoh N., Hirose T., Breier G., Vestweber D., CooperJ.A., Ohno S., Kaibuchi K., Adams R.H.: Spatial regulation of VEGFreceptor endocytosis in angiogenesis. Nat. Cell Biol., 2013; 15: 249-260
  Google Scholar
• 28. Nath B., Szabo G.: Hypoxia and hypoxia inducible factors: diverseroles in liver diseases. Hepatology, 2012; 55: 622-633
  Google Scholar
• 29. Nishiyama A., Konishi Y., Ohashi N., Morikawa T., UrushiharaM., Maeda I., Hamada M., Kishida M., Hitomi H., Shirahashi N., KoboriH., Imanishi M.: Urinary angiotensinogen reflects the activityof intrarenal renin-angiotensin system in patients with IgA nephropathy.Nephrol. Dial. Transplant., 2011; 26: 170-177
  Google Scholar
• 30. Pietilä R., Nätynki M., Tammela T., Kangas J., Pulkki K.H., LimayeN., Vikkula M., Koh G.Y., Saharinen P., Alitalo K., Eklund L.:Ligand oligomerization state controls Tie2 receptor trafficking andangiopoietin-2-specific responses. J. Cell Sci., 2012; 125: 2212-2223
  Google Scholar
• 31. Reinders M.E., Rabelink T.J., Briscoe D.M.: Angiogenesis and endothelialcell repair in renal disease and allograft rejection. J. Am.Soc. Nephrol., 2006; 17: 932-942
  Google Scholar
• 32. Rodríguez-Iturbe B., Franco M., Tapia E., Quiroz Y., Johnson R.J.:Renal inflammation, autoimmunity and salt-sensitive hypertension.Clin. Exp. Pharmacol. Physiol., 2012; 39: 96-103
  Google Scholar
• 33. Rutkowski B., Tylicki L., Manitius J., Lysiak-Szydlowska W.: Hypertensivenephropathy – an increasing clinical problem. Miner.Electrolyte Metab., 1999, 25: 65-68
  Google Scholar
• 34. Scharpfenecker M., Fiedler U., Reiss Y., Augustin H.G.: The Tie-2ligand angiopoietin-2 destabilizes quiescent endothelium throughan internal autocrine loop mechanism. J. Cell Sci., 2005; 118: 771-780
  Google Scholar
• 35. Schrimpf C., Xin C., Campanholle G., Gill S.E., Stallcup W., LinS.L., Davis G.E., Gharib S.A., Humphreys B.D., Duffield J.S.: PericyteTIMP3 and ADAMTS1 modulate vascular stability after kidney injury.J. Am. Soc. Nephrol., 2012; 23: 868-883
  Google Scholar
• 36. Souma T., Yamazaki S., Moriguchi T., Suzuki N., Hirano I., Pan X.,Minegishi N., Abe M., Kiyomoto H., Ito S., Yamamoto M.: Plasticityof renal erythropoietin-producing cells governs fibrosis. J. Am. Soc.Nephrol., 2013; 24: 1599-1616
  Google Scholar
• 37. Sulikowska B., Johnson R.J., Odrowąż-Sypniewska G., Manitius J.:Uric acid, renal vasoconstriction and erythropoietin relationship inIgA nephropathy revealed by dopamine-induced glomerular filtrationresponse. Kidney Blood Press. Res., 2012; 35: 161-166
  Google Scholar
• 38. Sun D., Ma Y., Han H., Yin Z., Liu C., Feng J., Zhou X., Li X., Xiao A.,Yu R.: Thrombospondin-1 short hairpin RNA suppresses tubulointerstitialfibrosis in the kidney of ureteral obstruction by amelioratingperitubular capillary injury. Kidney Blood Press. Res., 2012; 35: 35-47
  Google Scholar
• 39. Tan R.J., Liu Y.: Matrix metalloproteinases in kidney homeostasisand diseases. Am. J. Physiol. Renal Physiol., 2012; 302: F1351-F1361
  Google Scholar
• 40. Tasnim F., Zink D.: Cross talk between primary human renal tubularcells and endothelial cells in cocultures. Am. J. Physiol. RenalPhysiol., 2012; 302: F1055-F1062
  Google Scholar
• 41. Textor S.C., Misra S., Oderich G.S.: Percutaneous revascularizationfor ischemic nephropathy: the past, present, and future. KidneyInt., 2013; 83: 28-40
  Google Scholar
• 42. Tylicki L., Rutkowski B., Hörl W.H.: Multifactorial determinationof hypertensive nephroangiosclerosis. Kidney Blood Press. Res.,2002, 25: 341-353
  Google Scholar
• 43. Tylicki L., Rutkowski P., Renke M., Larczyński W., AleksandrowiczE., Lysiak-Szydlowska W., Rutkowski B.: Triple pharmacologicalblockade of the renin-angiotensin-aldosterone system in nondiabeticCKD: an open-label crossover randomized controlled trial. Am. J.Kidney Dis., 2008; 52: 486-493
  Google Scholar
• 44. Zeisberg M., Neilson E.G.: Mechanisms of tubulointerstitial fibrosis.J. Am. Soc. Nephrol., 2010; 21: 1819-1834
  Google Scholar

Pełna treść artykułu